October 08, 2020 Mapping the transatlantic divide for biotech flotations A look at how drug developers fare after floating in Europe suggests why many tread a path to the US and a Nasdaq listing.
December 05, 2018 Noxxon nears crucial combo readout The tiny German biotech needs strong signals to emerge from an approaching read out of its chemokine-targeting lead project.
October 24, 2018 Esmo 2018 – Adaptimmune gets the wooden spoon The company emerges as the worst-performing stock after Europe’s most important cancer conference, which claims numerous other victims.
June 07, 2018 Asco 2018 event analyser – A year of reset expectations Deciphera Pharmaceuticals emerges as one of the Asco 2018 winner as Jounce Therapeutics falls on weak data.